GlycoMimetics Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include Actuate Therapeutics.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Actuate Therapeutics Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases. | |
Founding Date | Founding Date 2003 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ | Locations Fort Worth, US HQ Dublin, IE |
Employees | Employees 5025% increase | Employees 1067% increase |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 180.3 m |
Financial | ||
Net income | Net income ($153.9m) (FY, 2025) | Net income ($22.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 101.8m | Total funding raised $ 31.2m |
For sources of this data, please see the company profile
View Company Profiles
Actuate Therapeutics
HQ
Fort Worth, US
Employees
10
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases.
View company